title: Alzheimer's disease research in the context of the national plan to address Alzheimer's disease.
abstract: In 2012, the first National Plan to Address Alzheimer's Disease in the United States (U.S.) was released, a component of the National Alzheimer's Project Act legislation. Since that time, there have been incremental increases in U.S. federal funding for Alzheimer's disease and related dementia research, particularly in the areas of biomarker discovery, genetic link and related biological underpinnings, and prevention studies for Alzheimer's. A central theme in each of these areas has been the emphasis of cross-sector collaboration and private-public partnerships between government, non-profit organizations and for-profit organizations. This paper will highlight multiple private-public partnerships supporting the advancement of Alzheimer's research in the context of the National Plan to Address Alzheimer's.
authors.affiliation: Alzheimer's Association, Medical & Scientific Relations, Chicago, IL, USA. Electronic address: hsnyder@alz.org.
authors.forename: Heather M
authors.initials: HM
authors.lastname: Snyder
authors.affiliation: Alzheimer's Association, Medical & Scientific Relations, Chicago, IL, USA.
authors.forename: James
authors.initials: J
authors.lastname: Hendrix
authors.affiliation: Independent Science Writer, Philadelphia, PA, USA.
authors.forename: Lisa J
authors.initials: LJ
authors.lastname: Bain
authors.affiliation: Alzheimer's Association, Medical & Scientific Relations, Chicago, IL, USA.
authors.forename: Maria C
authors.initials: MC
authors.lastname: Carrillo
mesh_terms: D000544:Alzheimer Disease / Q000453:epidemiology* / Q000473:pathology; D035843:Biomedical Research / Q000331:legislation & jurisprudence; D003704:Dementia / Q000453:epidemiology* / Q000473:pathology; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D055818:Public-Private Sector Partnerships / Q000331:legislation & jurisprudence; D014481:United States
keywords: Alzheimer's disease; Biomarkers; Collaborations; Dementia; Genetics; Partnerships; Prevention